ES2018860B3 - Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos - Google Patents

Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos

Info

Publication number
ES2018860B3
ES2018860B3 ES88104163T ES88104163T ES2018860B3 ES 2018860 B3 ES2018860 B3 ES 2018860B3 ES 88104163 T ES88104163 T ES 88104163T ES 88104163 T ES88104163 T ES 88104163T ES 2018860 B3 ES2018860 B3 ES 2018860B3
Authority
ES
Spain
Prior art keywords
preparation
thenyloxide
procedure
content
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88104163T
Other languages
English (en)
Inventor
Dieter Binder
Franz Rovenszky
Hubert Peter Ferber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cl Pharma AG
Original Assignee
Cl Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cl Pharma AG filed Critical Cl Pharma AG
Application granted granted Critical
Publication of ES2018860B3 publication Critical patent/ES2018860B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES88104163T 1987-04-03 1988-03-16 Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos Expired - Lifetime ES2018860B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT82087 1987-04-03

Publications (1)

Publication Number Publication Date
ES2018860B3 true ES2018860B3 (es) 1991-05-16

Family

ID=3500502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88104163T Expired - Lifetime ES2018860B3 (es) 1987-04-03 1988-03-16 Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos

Country Status (25)

Country Link
US (1) US4877809A (es)
EP (1) EP0284892B1 (es)
JP (1) JPH0813809B2 (es)
KR (1) KR960005463B1 (es)
AT (1) ATE57925T1 (es)
AU (1) AU596738B2 (es)
CA (1) CA1320492C (es)
CS (1) CS274570B2 (es)
DD (1) DD268472A5 (es)
DE (1) DE3860908D1 (es)
ES (1) ES2018860B3 (es)
FI (1) FI87780C (es)
GR (1) GR3001056T3 (es)
HK (1) HK81991A (es)
HU (2) HU201048B (es)
IL (1) IL85781A (es)
MY (1) MY103236A (es)
NO (1) NO170414C (es)
NZ (1) NZ224094A (es)
PH (1) PH24742A (es)
PL (1) PL150011B1 (es)
SG (1) SG78391G (es)
SU (1) SU1574176A3 (es)
YU (1) YU48300B (es)
ZA (1) ZA882031B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783597A (en) * 1997-03-04 1998-07-21 Ortho Pharmaceutical Corporation 2,5-disubstituted thiophenes: inhibitors of 5-lipoxygenase and inducible cyclooxygenase (COX-2) enzymes, composition and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832354A (en) * 1972-08-01 1974-08-27 Sandoz Ltd 4-hydroxy-5-phenyl-3-thiophene acetic acids and their derivatives
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
FR2495156A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Derives de la thieno-pyridinone, leur procede de preparation et leur application therapeutique
AT376436B (de) * 1982-11-05 1984-11-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon

Also Published As

Publication number Publication date
IL85781A (en) 1992-08-18
CS274570B2 (en) 1991-08-13
FI87780B (fi) 1992-11-13
KR960005463B1 (ko) 1996-04-25
JPS63258873A (ja) 1988-10-26
GR3001056T3 (en) 1992-03-20
ATE57925T1 (de) 1990-11-15
SG78391G (en) 1991-12-13
HK81991A (en) 1991-10-25
FI881504A0 (fi) 1988-03-30
JPH0813809B2 (ja) 1996-02-14
EP0284892A1 (de) 1988-10-05
CA1320492C (en) 1993-07-20
PL150011B1 (en) 1990-04-30
NZ224094A (en) 1990-02-26
NO170414B (no) 1992-07-06
CS218988A2 (en) 1990-10-12
KR880012585A (ko) 1988-11-28
YU48300B (sh) 1998-05-15
NO881279D0 (no) 1988-03-23
PH24742A (en) 1990-10-01
HUT50161A (en) 1989-12-28
FI87780C (fi) 1993-02-25
ZA882031B (en) 1988-09-15
AU596738B2 (en) 1990-05-10
PL271546A1 (en) 1989-01-05
EP0284892B1 (de) 1990-10-31
DD268472A5 (de) 1989-05-31
HU201048B (en) 1990-09-28
YU65188A (en) 1989-10-31
US4877809A (en) 1989-10-31
SU1574176A3 (ru) 1990-06-23
FI881504A (fi) 1988-10-04
AU1405988A (en) 1988-10-06
DE3860908D1 (de) 1990-12-06
NO881279L (no) 1988-10-04
MY103236A (en) 1993-05-29
IL85781A0 (en) 1988-09-30
NO170414C (no) 1992-10-14

Similar Documents

Publication Publication Date Title
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
MX11031A (es) Proceso para la preparacion de nuevas 1-fenil-3-naftaleniloxipropanaminas producto obtenido y composicion farmaceutica que lo incluye.
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
PT89788A (pt) Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
SE8700714D0 (sv) Anvendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat for framstellning av lekemedel for behandling av sjukdomar i matsmeltningskanalen och som antiulcerost lekemedel
SE7902100L (sv) 1-substituerade tiometyltriazolobensodiazepiner och framstellning derav
ES2018860B3 (es) Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos
DE3671224D1 (de) 1-phenyl-3-benzazepine.
DK176788A (da) Thienyloxyeddikesyrederivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse
EP0316939A3 (en) Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use
FI870045A0 (fi) Nya kvaevearylmetoxi-tiofenderivat och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
NO154091C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater.
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
RU96105981A (ru) Применение сложных эфиров n-алкилированной 1,4-дигидропиридиндикарбоновой кислоты в качестве лекарственного средства